Showing results (521-530 of 794) with videos related to

Sort By:
Pageof 80
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Antiretroviral resistance during successful therapy of HIV type 1 infectionJ Martinez-Picado, M P DePasquale, N Kartsonis, et al.
JAMA|August 5, 2008
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panelScott M Hammer, Joseph J Eron, Peter Reiss, et al.
JAMA Internal Medicine|November 25, 2014
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individualsJason F Okulicz, Tuan D Le, Brian K Agan, et al.
Virology|May 24, 2008
Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimeticsJosh D Nelson, Heather Kinkead, Florence M Brunel, et al.
The Journal of Experimental Medicine|December 15, 2004
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptorTao Dong, Guillaume Stewart-Jones, Nan Chen, et al.
The Journal of Pathology|December 23, 2015
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trialsSusan D Richman, Katie Southward, Philip Chambers, et al.
The Journal of Experimental Medicine|July 6, 2000
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic functionV Appay, D F Nixon, S M Donahoe, et al.
Scientific Reports|September 19, 2024
The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples, alongside routine gene mutation testingKanishta Srihar, Arief Gusnanto, Susan D Richman, et al.
Nature Medicine|August 9, 2016
Defective proviruses rapidly accumulate during acute HIV-1 infectionKatherine M Bruner, Alexandra J Murray, Ross A Pollack, et al.
BMJ Open|November 10, 2025
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, Alexandra Gilbert, Duncan Gilbert, et al.
Pageof 80